Skip to content

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD

company.status.inactive

CIK 1400482fmd_1WDZ6Z232J0RAWHJ0H2KV3W4KJManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Mar 31, 2017, 18 periods

Latest annual · FY2016

Millions
Total revenues
8
Operating income
(36)
Net income
(35)
Free cash flow
(28)

Latest quarter · Q1 FY2017

Millions
Total revenues
0
Operating income
(9)
Net income
(9)
Free cash flow
(8)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2013 to FY2016
-47.6%

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2016FY2015ChangeSource
Revenue$7.6 million$24.1 million-68.4%10-K 2017-03-15 · proof
Operating income-$36 million-$26.6 million10-K 2017-03-15 · proof
Net income-$34.5 million-$25.5 million10-K 2017-03-15 · proof
Cash from operating activities-$27.5 million-$16.9 million10-K 2017-03-15 · proof
Free cash flow-$27.7 million-$17.4 million10-K 2017-03-15 · proof
Total assets$147.4 million$176 million-16.2%10-K 2017-03-15 · proof
Total liabilities$5.6 million$9.5 million-41.5%10-K 2017-03-15 · proof
Cash and cash equivalents$8.9 million$5.1 million+75.9%10-K 2017-03-15 · proof
What was KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's revenue in fiscal 2016?
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported revenue of $7.6 million for fiscal 2016 (the year ended Dec 31, 2016), against $24.1 million the year before (-68.4%). Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What was KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's operating income in fiscal 2016?
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported operating income of -$36 million for fiscal 2016 (the year ended Dec 31, 2016), against -$26.6 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What was KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's net income in fiscal 2016?
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported net income of -$34.5 million for fiscal 2016 (the year ended Dec 31, 2016), against -$25.5 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What was KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's cash from operating activities in fiscal 2016?
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported cash from operating activities of -$27.5 million for fiscal 2016 (the year ended Dec 31, 2016), against -$16.9 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What was KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's free cash flow in fiscal 2016?
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported free cash flow of -$27.7 million for fiscal 2016 (the year ended Dec 31, 2016), against -$17.4 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What are KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's total assets?
As of Dec 31, 2016, KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported total assets of $147.4 million, against $176 million a year earlier (-16.2%). Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What are KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's total liabilities?
As of Dec 31, 2016, KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported total liabilities of $5.6 million, against $9.5 million a year earlier (-41.5%). Source: the 10-K filed with the SEC on Mar 15, 2017. SEC
What are KUBOTA PHARMACEUTICAL HOLDINGS CO LTD's cash and cash equivalents?
As of Dec 31, 2016, KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported cash and cash equivalents of $8.9 million, against $5.1 million a year earlier (+75.9%). Source: the 10-K filed with the SEC on Mar 15, 2017. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1400482&period_type=annual&limit=5"

Information only, not investment advice.